Show simple item record

Files in this item


Item metadata

dc.contributor.authorIşbilir, Ali
dc.contributor.authorMöller, Jan
dc.contributor.authorArimont, Marta
dc.contributor.authorBobkov, Vladimir
dc.contributor.authorPerpiñá-Viciano, Cristina
dc.contributor.authorHoffmann, Carsten
dc.contributor.authorInoue, Asuka
dc.contributor.authorHeukers, Raimond
dc.contributor.authorde Graaf, Chris
dc.contributor.authorSmit, Martine J.
dc.contributor.authorAnnibale, Paolo
dc.contributor.authorLohse, Martin J.
dc.identifier.citationIşbilir , A , Möller , J , Arimont , M , Bobkov , V , Perpiñá-Viciano , C , Hoffmann , C , Inoue , A , Heukers , R , de Graaf , C , Smit , M J , Annibale , P & Lohse , M J 2020 , ' Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists ' , Proceedings of the National Academy of Sciences of the United States of America , vol. 117 , no. 46 , pp. 29144-29154 .
dc.identifier.otherPURE: 277342165
dc.identifier.otherPURE UUID: e79da2b8-ad31-4214-81aa-72dc0f284867
dc.identifier.otherScopus: 85096357712
dc.identifier.otherPubMed: 33148803
dc.identifier.otherORCID: /0000-0003-3208-5347/work/105957261
dc.descriptionFunding: This research was funded by European Union’s Horizon2020 Marie Skłodowska-Curie Actions (MSCA) Program under Grant Agreement 641833 (ONCORNET) and European Cooperation in Science and Technology (COST) Action CA18133 European Research Network on Signal Transduction (ERNEST). A. Inoue was funded by the Leading Advanced Projects for Medical Innovation (LEAP) JP19gm0010004 from the Japan Agency for Medical Research and Development.en
dc.description.abstractAlthough class A G protein−coupled receptors (GPCRs) can function as monomers, many of them form dimers and oligomers, but the mechanisms and functional relevance of such oligomerization is ill understood. Here, we investigate this problem for the CXC chemokine receptor 4 (CXCR4), a GPCR that regulates immune and hematopoietic cell trafficking, and a major drug target in cancer therapy. We combine single-molecule microscopy and fluorescence fluctuation spectroscopy to investigate CXCR4 membrane organization in living cells at densities ranging from a few molecules to hundreds of molecules per square micrometer of the plasma membrane. We observe that CXCR4 forms dynamic, transient homodimers, and that the monomer−dimer equilibrium is governed by receptor density. CXCR4 inverse agonists that bind to the receptor minor pocket inhibit CXCR4 constitutive activity and abolish receptor dimerization. A mutation in the minor binding pocket reduced the dimer-disrupting ability of these ligands. In addition, mutating critical residues in the sixth transmembrane helix of CXCR4 markedly diminished both basal activity and dimerization, supporting the notion that CXCR4 basal activity is required for dimer formation. Together, these results link CXCR4 dimerization to its density and to its activity. They further suggest that inverse agonists binding to the minor pocket suppress both dimerization and constitutive activity and may represent a specific strategy to target CXCR4.
dc.relation.ispartofProceedings of the National Academy of Sciences of the United States of Americaen
dc.rightsCopyright © 2020 the Author(s). This open access article is distributed under Creative Commons Attribution-NonCommercialNoDerivatives License 4.0 (CC BY-NC-ND).en
dc.subjectChemokine receptoren
dc.subjectBasal activityen
dc.subjectQH301 Biologyen
dc.subjectRM Therapeutics. Pharmacologyen
dc.titleAdvanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonistsen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Physics and Astronomyen
dc.description.statusPeer revieweden

This item appears in the following Collection(s)

Show simple item record